次世代シーケンシングの世界市場2017-2026

◆英語タイトル:Next Generation Sequencing - Global Market Outlook (2017-2026)
◆商品コード:SMRC809033
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2018年8月20日
◆ページ数:191
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、次世代シーケンシングの世界市場について調査・分析し、市場概要、市場環境、次世代シーケンシング市場規模、シーケンシングのタイプ別(全ゲノムシーケンシング、標的再シーケンシング、全エキソームシーケンシング、RNAシーケンシング、CHIPシーケンシング、De Novo シーケンシング、メチルシークエンシング、単一分子リアルタイムシーケンシング、事前シーケンシング)分析、製品別(機器、試薬・消耗品、サービス、プラットフォーム)分析、 用途別(生殖医療、腫瘍学、HLAタイピング・免疫システムモニタリング、メタゲノミクス、疫学・医薬品開発、アグリゲノミックス・フォレンジック、コンシューマーゲノミクス、臨床試験)分析、エンドユーザー別(農薬、病院、学術期間、バイオテクノロジー・製薬企業、創薬・オーダーメイド医療、遺伝子スクリーニング、診断・感染症、農業・動物研究、その他)分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・ エグゼクティブサマリー
・ 序文
・ 次世代シーケンシングの世界市場:市場動向分析
・ 次世代シーケンシングの世界市場:競争要因分析
・ 次世代シーケンシングの世界市場:シーケンシングのタイプ別(全ゲノムシーケンシング、標的再シーケンシング、全エキソームシーケンシング、RNAシーケンシング、CHIPシーケンシング、De Novo シーケンシング、メチルシークエンシング、単一分子リアルタイムシーケンシング、事前シーケンシング)
・ 次世代シーケンシングの世界市場:製品別(機器、試薬・消耗品、サービス、プラットフォーム)
・ 次世代シーケンシングの世界市場: 用途別(生殖医療、腫瘍学、HLAタイピング・免疫システムモニタリング、メタゲノミクス、疫学・医薬品開発、アグリゲノミックス・フォレンジック、コンシューマーゲノミクス、臨床試験)
・ 次世代シーケンシングの世界市場:エンドユーザー別(農薬、病院、学術期間、バイオテクノロジー・製薬企業、創薬・オーダーメイド医療、遺伝子スクリーニング、診断・感染症、農業・動物研究、その他)
・ 次世代シーケンシングの世界市場:主要地域別分析
・ 次世代シーケンシングの北米市場規模(アメリカ市場等)
・ 次世代シーケンシングのヨーロッパ市場規模
・ 次世代シーケンシングのアジア市場規模(日本市場、中国市場、インド市場等)
・次世代シーケンシングの世界市場:主な市場開拓
・ 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Next Generation Sequencing market is expected to grow at a CAGR of 18.7% during the forecast period. Factors such as growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. On the other side, accuracy and standardization issues and lack of skilled labour are inhibiting the market growth. However, rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

Next-generation sequencing enables rapid sequencing and produces millions of DNA and RNA sequences. It is otherwise called as massively parallel sequencing technology used in personalized medicines, clinical applications, animal research and other applications.

Depending upon the End Users, the Genetic Screening is a method used to provide important information on gene function as well as the molecular events that underlie a biological process or pathway or identify and select for individuals who possess a phenotype of interest in a mutagenized population. It totally depends on the accuracy of the test, the reliability of the interpretation of the results and the ability to treat the condition based on the quality. Apart from these, it can lessen the anxiety of not knowing the possibility of developing a disease and give a tremendous sense of relief.

By geography, North America is expected to surpass the other regions throughout the forecast period due to the support from various government bodies, like NHGRI (National Human Genome Research Institute, US) and fund research on the genome’s structure, function, and role in health and disease.

Some of the key players in Next Generation Sequencing market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Illumina, Inc., Beijing Genomics Institute, Qiagen N.V., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Agilent Technologies, Inc., Gatc Biotech AG, Oxford Nanopore Technologies, Ltd., Macrogen, Inc., Eurofins Scientific, Myriad Genetics, Bio-Rad Laboratories, Inc., Pieriandx, Roche Holding Ag, Genomatix Gmbh, DNASTAR Inc., Macrogen Inc. and Helicos BioSciences.

Type of Sequencing covered:
• Whole Genome Sequencing
• Targeted Resequencing
• Whole Exome Sequencing
• RNA Sequencing
• CHIP Sequencing
• De Novo Sequencing
• Methyl Sequencing
• Pre-sequencing

Products Covered:
• Instruments
• Reagents & Consumables
• Services
• Platforms

Applications Covered:
• Reproductive Health
• Oncology
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics
• Clinical Investigation

End Users Covered:
• Hospitals
• Academics
• Biotech and Pharmaceutical Firms
• Next Generation Sequencing Market By Application
• Drug Discovery/Personalized Medicine
• Genetic Screening
• Diagnostics/Infectious Diseases
• Agriculture and Animal Research
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Next-Generation Sequencing Market, By Type of Sequencing
5.1 Introduction
5.2 Whole Genome Sequencing
5.3 Targeted Resequencing
5.3.1 DNA Based Targeted Sequencing
5.3.2 RNA Based Targeted Sequencing
5.4 Whole Exome Sequencing
5.5 RNA Sequencing
5.6 CHIP Sequencing
5.7 De Novo Sequencing
5.8 Methyl Sequencing
5.9 Single-Molecule Real-Time Sequencing
5.10 Pre-sequencing
5.10.1 NGS Semi-Automated Library Preparation
5.10.2 NGS Automated Library Preparation
5.10.3 Clonal Amplification

6 Global Next-Generation Sequencing Market, By Product
6.1 Introduction
6.2 Instruments
6.2.1 Integrated Workflow Instruments
6.2.2 Sequencing Instruments
6.2.3 Library Preparation Instruments
6.3 Reagents & Consumables
6.3.1 Library Preparation Kits
6.3.2 Target Enrichment Kits
6.3.3 Sequencing Kits
6.3.4 Multiuse Kits
6.4 Services
6.5 Platforms
6.5.1 Illumina
6.5.1.1 Hiseq Series
6.5.1.2 Hiseq X Ten & Hiseq X Five
6.5.1.3 Miseq Series
6.5.1.4 Nextseq 500
6.5.1.5 Miniseq
6.5.2 Thermo Fisher Scientific (Life Technologies)
6.5.2.1 ION PGM
6.5.2.2 ION Proton
6.5.2.3 ION S5 & S5 XL
6.5.3 Pacific Biosciences
6.5.3.1 Pacbio Rs II
6.5.3.2 Sequel System
6.5.4 Oxford Nanopore
6.5.5 Other Next-Generation Sequencing Platforms
6.5.6 Recently Launched Sequencing Platforms

7 Global Next-Generation Sequencing Market, By Application
7.1 Introduction
7.2 Reproductive Health
7.2.1 Non Invasive Prenatal Test
7.2.2 Preimplantation Genetic Testing
7.2.3 Newborn/Genetic Screening
7.3 Oncology
7.4 HLA Typing/Immune System Monitoring
7.5 Metagenomics, Epidemiology & Drug Development
7.6 Agrigenomics & Forensics
7.7 Consumer Genomics
7.8 Clinical Investigation
7.8.1 Idiopathic Diseases
7.8.2 Inherited Diseases
7.8.3 Infectious Diseases
7.8.4 Non-Communicable / Other Diseases

8 Global Next-Generation Sequencing Market, By End User
8.1 Introduction
8.2 Pesticides
8.3 Hospitals
8.4 Academics
8.5 Biotech and Pharmaceutical Firms
8.6 Drug Discovery/Personalized Medicine
8.7 Genetic Screening
8.8 Diagnostics/Infectious Diseases
8.9 Agriculture and Animal Research
8.10 Other End Users

9 Global Next-Generation Sequencing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Acquisitions & Mergers
10.2 Agreements, Partnerships, Collaborations and Joint Ventures
10.3 Product Launch & Expansions
10.4 Other Activities

11 Company Profiling
9.1 Thermo Fisher Scientific Inc.
9.2 F. Hoffmann-La Roche AG
9.3 Illumina, Inc.
9.4 Beijing Genomics Institute
9.5 Qiagen N.V.
9.6 Pacific Biosciences of California, Inc.
9.7 Perkinelmer, Inc.
9.8 Agilent Technologies, Inc.
9.9 Gatc Biotech AG
9.10 Oxford Nanopore Technologies, Ltd.
9.11 Macrogen, Inc.
9.12 Eurofins Scientific
9.13 Myriad Genetics
9.14 Bio-Rad Laboratories, Inc.
9.15 Pieriandx
9.16 Roche Holding Ag
9.17 Genomatix Gmbh
9.18 DNASTAR Inc.
9.19 Macrogen Inc.
9.20 Helicos BioSciences

List of Tables
Table 1 Global Next-Generation Sequencing Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Next-Generation Sequencing Market Outlook, By Type of Sequencing (2016-2026) ($MN)
Table 3 Global Next-Generation Sequencing Market Outlook, By Whole Genome Sequencing (2016-2026) ($MN)
Table 4 Global Next-Generation Sequencing Market Outlook, By Targeted Resequencing (2016-2026) ($MN)
Table 5 Global Next-Generation Sequencing Market Outlook, By DNA Based Targeted Sequencing (2016-2026) ($MN)
Table 6 Global Next-Generation Sequencing Market Outlook, By RNA Based Targeted Sequencing (2016-2026) ($MN)
Table 7 Global Next-Generation Sequencing Market Outlook, By Whole Exome Sequencing (2016-2026) ($MN)
Table 8 Global Next-Generation Sequencing Market Outlook, By RNA Sequencing (2016-2026) ($MN)
Table 9 Global Next-Generation Sequencing Market Outlook, By CHIP Sequencing (2016-2026) ($MN)
Table 10 Global Next-Generation Sequencing Market Outlook, By De Novo Sequencing (2016-2026) ($MN)
Table 11 Global Next-Generation Sequencing Market Outlook, By Methyl Sequencing (2016-2026) ($MN)
Table 12 Global Next-Generation Sequencing Market Outlook, By Single-Molecule Real-Time Sequencing (2016-2026) ($MN)
Table 13 Global Next-Generation Sequencing Market Outlook, By Pre-sequencing (2016-2026) ($MN)
Table 14 Global Next-Generation Sequencing Market Outlook, By NGS Semi-Automated Library Preparation (2016-2026) ($MN)
Table 15 Global Next-Generation Sequencing Market Outlook, By NGS Automated Library Preparation (2016-2026) ($MN)
Table 16 Global Next-Generation Sequencing Market Outlook, By Clonal Amplification (2016-2026) ($MN)
Table 17 Global Next-Generation Sequencing Market Outlook, By Product (2016-2026) ($MN)
Table 18 Global Next-Generation Sequencing Market Outlook, By Instruments (2016-2026) ($MN)
Table 19 Global Next-Generation Sequencing Market Outlook, By Integrated Workflow Instruments (2016-2026) ($MN)
Table 20 Global Next-Generation Sequencing Market Outlook, By Sequencing Instruments (2016-2026) ($MN)
Table 21 Global Next-Generation Sequencing Market Outlook, By Library Preparation Instruments (2016-2026) ($MN)
Table 22 Global Next-Generation Sequencing Market Outlook, By Reagents & Consumables (2016-2026) ($MN)
Table 23 Global Next-Generation Sequencing Market Outlook, By Library Preparation Kits (2016-2026) ($MN)
Table 24 Global Next-Generation Sequencing Market Outlook, By Target Enrichment Kits (2016-2026) ($MN)
Table 25 Global Next-Generation Sequencing Market Outlook, By Sequencing Kits (2016-2026) ($MN)
Table 26 Global Next-Generation Sequencing Market Outlook, By Multiuse Kits (2016-2026) ($MN)
Table 27 Global Next-Generation Sequencing Market Outlook, By Services (2016-2026) ($MN)
Table 28 Global Next-Generation Sequencing Market Outlook, By Platforms (2016-2026) ($MN)
Table 29 Global Next-Generation Sequencing Market Outlook, By Illumina (2016-2026) ($MN)
Table 30 Global Next-Generation Sequencing Market Outlook, By Thermo Fisher Scientific (Life Technologies) (2016-2026) ($MN)
Table 31 Global Next-Generation Sequencing Market Outlook, By Pacific Biosciences (2016-2026) ($MN)
Table 32 Global Next-Generation Sequencing Market Outlook, By Oxford Nanopore (2016-2026) ($MN)
Table 33 Global Next-Generation Sequencing Market Outlook, By Other Next-Generation Sequencing Platforms (2016-2026) ($MN)
Table 34 Global Next-Generation Sequencing Market Outlook, By Recently Launched Sequencing Platforms (2016-2026) ($MN)
Table 35 Global Next-Generation Sequencing Market Outlook, By Application (2016-2026) ($MN)
Table 36 Global Next-Generation Sequencing Market Outlook, By Reproductive Health (2016-2026) ($MN)
Table 37 Global Next-Generation Sequencing Market Outlook, By Non Invasive Prenatal Test (2016-2026) ($MN)
Table 38 Global Next-Generation Sequencing Market Outlook, By Preimplantation Genetic Testing (2016-2026) ($MN)
Table 39 Global Next-Generation Sequencing Market Outlook, By Newborn/Genetic Screening (2016-2026) ($MN)
Table 40 Global Next-Generation Sequencing Market Outlook, By Oncology (2016-2026) ($MN)
Table 41 Global Next-Generation Sequencing Market Outlook, By HLA Typing/Immune System Monitoring (2016-2026) ($MN)
Table 42 Global Next-Generation Sequencing Market Outlook, By Metagenomics, Epidemiology & Drug Development (2016-2026) ($MN)
Table 43 Global Next-Generation Sequencing Market Outlook, By Agrigenomics & Forensics (2016-2026) ($MN)
Table 44 Global Next-Generation Sequencing Market Outlook, By Consumer Genomics (2016-2026) ($MN)
Table 45 Global Next-Generation Sequencing Market Outlook, By Clinical Investigation (2016-2026) ($MN)
Table 46 Global Next-Generation Sequencing Market Outlook, By Idiopathic Diseases (2016-2026) ($MN)
Table 47 Global Next-Generation Sequencing Market Outlook, By Inherited Diseases (2016-2026) ($MN)
Table 48 Global Next-Generation Sequencing Market Outlook, By Infectious Diseases (2016-2026) ($MN)
Table 49 Global Next-Generation Sequencing Market Outlook, By Non-Communicable / Other Diseases (2016-2026) ($MN)
Table 50 Global Next-Generation Sequencing Market Outlook, By End User (2016-2026) ($MN)
Table 51 Global Next-Generation Sequencing Market Outlook, By Hospitals (2016-2026) ($MN)
Table 52 Global Next-Generation Sequencing Market Outlook, By Academics (2016-2026) ($MN)
Table 53 Global Next-Generation Sequencing Market Outlook, By Biotech and Pharmaceutical Firms (2016-2026) ($MN)
Table 54 Global Next-Generation Sequencing Market Outlook, By Drug Discovery/Personalized Medicine (2016-2026) ($MN)
Table 55 Global Next-Generation Sequencing Market Outlook, By Genetic Screening (2016-2026) ($MN)
Table 56 Global Next-Generation Sequencing Market Outlook, By Diagnostics/Infectious Diseases (2016-2026) ($MN)
Table 57 Global Next-Generation Sequencing Market Outlook, By Agriculture and Animal Research (2016-2026) ($MN)
Table 58 Global Next-Generation Sequencing Market Outlook, By Other End Users (2016-2026) ($MN)

NOTE: North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in above manner.



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[次世代シーケンシングの世界市場2017-2026]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆